HER2 Expressing Solid Tumors

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-07-16
Clinical Trial Update: Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors [Phase 1, Phase 2]
Dose escalation study of ADXS31-164 in HER2-expressing solid tumors has completed Phase 1/2 trials.